<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE314nnn/GSE314094/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Rattus norvegicus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314094</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Pre-emptive Post-Reperfusion Cardioprotection with a Small Molecule in Rodents that Suppresses Genes Predictive of Heart Failure in Reperfused STEMI Patients</name><description>We determined the post-reperfusion cardioprotective properties of BT2 in rat models of M/IR injury. Single nucleus RNA-seq of the AAR revealed that BT2 modulated the expression of key regulators of heart function, inflammation, extracellular matrix production and fibrosis, particularly in macrophages and myofibroblasts. Bulk RNA-seq showed BT2 downregulated multiple genes in the AAR associated with disease severity in ACS patients as well as genes predictive of HF in ST-elevation myocardial infarction (STEMI) patients undergoing PCI, including cytokines, inflammasome, damage-associated molecular patterns (DAMPs), DAMP-sensing receptors and biomarkers of HF.</description><dates><publication>2026/05/20</publication></dates><accession>GSE314094</accession><cross_references><GSM>GSM9381454</GSM><GSM>GSM9381453</GSM><GSM>GSM9381452</GSM><GSM>GSM9381461</GSM><GSM>GSM9381460</GSM><GSM>GSM9381459</GSM><GSM>GSM9381458</GSM><GSM>GSM9381457</GSM><GSM>GSM9381456</GSM><GSM>GSM9381455</GSM><GPL>34877</GPL><GPL>20084</GPL><GSE>314094</GSE><taxon>Rattus norvegicus</taxon><PMID>[42127187]</PMID></cross_references></HashMap>